Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc.

188 F.R.D. 189, 52 U.S.P.Q. 2d (BNA) 1897, 1999 U.S. Dist. LEXIS 5950, 1999 WL 249728
CourtDistrict Court, S.D. New York
DecidedApril 27, 1999
DocketNo. 95 CIV. 8833(RPP)
StatusPublished
Cited by6 cases

This text of 188 F.R.D. 189 (Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc., 188 F.R.D. 189, 52 U.S.P.Q. 2d (BNA) 1897, 1999 U.S. Dist. LEXIS 5950, 1999 WL 249728 (S.D.N.Y. 1999).

Opinion

OPINION AND ORDER

ROBERT P. PATTERSON, Jr., District Judge.

By letters dated April 17, 1998 and May 5, 1998, Rhone-Poulenc Rorer, Inc. (“RPR”) requests reconsideration of this Court’s opinion and order dated March 31, 1998 relating to the French patent agent privilege, Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc., No. 95 CIV. 8833(RPP), 1998 WL 158958 (S.D.N.Y. April 2, 1998). In that opinion and order, the Court found that French patent agents are not entitled under French law to an evidentiary privilege comparable to the attorney-client privilege as it is enjoyed by patent attorneys under United States law. As a result, the Court held that unless RPR’s French patent agents were acting under the authority of an American attorney, the French patent agents’ communications and memoranda were not privileged. 1998 WL 158958, at *3. RPR’s request for reconsideration of this opinion and order was opposed by letters from Bristol-Myers Squibb Co. (“Bristol”) dated April 24, 1998 and May 7, 1998. After oral argument, the Court ordered a hearing on December 2-3, 1998, at which both sides presented expert testimony on foreign patent agent secrecy law.

For the reasons that follow, the Court finds that neither the evidence produced at the hearing nor any submissions by the parties provides a basis for disturbing the March 31,1998 opinion and order.

PROCEDURAL BACKGROUND

The Court’s March 31, 1998 opinion and order was, itself, decided on a motion to reconsider an earlier opinion and order dated February 6, 1998. The February 6, 1998 opinion and order, Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc. No. 95 CIV.8833(RPP), 1998 WL 51847 (S.D.N.Y. Feb. 9, 1998), found that communications and memoranda prepared by RPR’s French patent agents, Jacques Pilard and Jacques Savina, were protected from discovery on three grounds: (1) Pilard and Savina were in-house patent agents qualified to prepare and prosecute French and European patent applications and to render legal advice with respect to French and European patent matters, which French law protects from discovery; (2) Pilard and Savina, as employees of RPR, were performing duties such as gathering, analyzing and transmitting factual and technical information at the request of RPR’s outside patent agents and patent attorneys, which qualified them as “agents ... responsible for directing [the company’s] actions in response to legal advice” entitled to protection under Upjohn Co. v. United States, 449 U.S. 383, 391, 101 S.Ct. 677, 66 L.Ed.2d 584 (1981); and (3) since 1975 all of Pilard’s and Savina’s activities were conducted pursuant to a research collaboration and patent agreement with L’Université Joseph Fourier and the Centre National De La Recherche Scientifique, thereby entitling them to the protections of the attorney-client privilege for communications between counsel and clients under the community of interest doctrine as elaborated in In re Regents of the University of California, 101 F.3d 1386, 1389 (Fed.Cir.1996), cert. denied, 520 U.S. 1193, 117 S.Ct. 1484, 137 L.Ed.2d 695 (1997). Bristol-Myers, 1998 WL 51847, at *1. The Court found that exceptions to the general finding of privilege might apply to the documents of Dr. Ojima, a professor at the State University of New York; documents relating to Bristol’s crime-fraud defense; and documents relating to statements made by the inventors in applying for the ’277 patent reissue. Id. at *2. The Court ordered, with respect to communications to or from Pilard or Savina, that RPR identify on its privilege log the relevant patent or patent application and prior art so that Bristol could make a determination “as to whether Pilard and Savina were or were not engaged in providing legal advice with respect to French or European patent matters or were or were not acting as gatherers of factual and technical information at the instructions of outside [191]*191patent attorneys in the United States.” Id. at *2.

On March 31, 1998, the Court granted a motion for reconsideration of its February 6, 1998 opinion and order, and held that the communications to and from RPR’s French patent agents were not entitled to the attorney-client privilege. The Court adopted the position that “[i]f a communication with a foreign patent agent involves a foreign patent application, then as a matter of comity, the law of that foreign country is considered regarding whether the law provides a privilege comparable to the attorney/client privilege.” Bristol-Myers, 1998 WL 158958, at *1. The Court found that French patent agents have a duty to preserve the confidences of their clients, grounded in Article 422-54 of the French Intellectual Property Code, which applies to patent agents and states that they “must obey professional secrecy,” and in Article 378 of the French Penal Code, which states:

[P]ersons who are depositories, by their condition or profession or by temporary or permanent duties, of secrets which are entrusted to them, who, except in cases where the law obliges or authorizes them to be informers, shall have revealed such secrets, shall be punished by imprisonment of one month to six months and by a fine of 500 to 3,000 francs.

Id. at *l-*2.1 The Court noted, however, “the fact that a statute requires a party to keep clients’ affairs secret does not mean that a privilege exists,” id. at *3, and it concluded that, in fact, no evidentiary privilege covers French patent agents, id. The Court based this conclusion on Article 12.3 of the French regulations concerning the professional secrecy obligations of French patent agents, which states that “[t]he professional secrecy rules are not enforceable either against persons legally empowered to conduct judicial, administrative or customs investigations, or against courts of legal jurisdiction.” Id. at * 2.2 The Court likened the French professional secrecy obligation to that of bankers and telephone companies in this country, which requires such entities to abstain from divulging secrets of their clients’ affairs absent court process. Id. at *3. The Court found that the French patent agent requirement of secrecy was not comparable to the attorney-client privilege in this country, and that “unless the French patent agents were acting under the authority of a U.S, attorney, the French patent agents’ communications are not entitled to the protections afforded the attorney-client privilege in this country and, thus, are not entitled to comity.” Id. at *3 (citing Status Time Corp. v. Sharp Elecs. Corp., 95 F.R.D. 27, 31-33 (S.D.N.Y.1982); Golden Trade, S.r.L. v. Lee Apparel Co., 143 F.R.D. 514, 519 (S.D.N.Y.1992); Glaxo, Inc. v. Novopharm Ltd., 148 F.R.D. 535, 539 (E.D.N.C. 1993)).

RPR moved for reconsideration of the March 31, 1998 opinion and order, and after oral argument on June 5, 1998, the Court ordered that a hearing be held so that the parties could present testimony from experts in French law as to the scope of the French patent agent’s secrecy obligation and the extent of any evidentiary privilege.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Suber v. VVP Services, LLC
S.D. New York, 2023
In re Rivastigimine Patent Litigation
239 F.R.D. 351 (S.D. New York, 2006)
In re Rivastigmine Patent Litigation
237 F.R.D. 69 (S.D. New York, 2006)
Aktiebolag v. Andrx Pharmaceuticals, Inc.
208 F.R.D. 92 (S.D. New York, 2002)
VLT Corp. v. Unitrode Corp.
194 F.R.D. 8 (D. Massachusetts, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
188 F.R.D. 189, 52 U.S.P.Q. 2d (BNA) 1897, 1999 U.S. Dist. LEXIS 5950, 1999 WL 249728, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bristol-myers-squibb-co-v-rhone-poulenc-rorer-inc-nysd-1999.